| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.79▲ | 9.79▲ | 9.79▲ | 9.85▼ | 9.79▲ |
| MA10 | 9.80▼ | 9.81▼ | 9.83▼ | 9.81▼ | 9.72▲ |
| MA20 | 9.83▼ | 9.83▼ | 9.84▼ | 9.77▲ | 9.80▼ |
| MA50 | 9.82▼ | 9.80▼ | 9.79▲ | 9.71▲ | 9.75▲ |
| MA100 | 9.79▲ | 9.71▲ | 9.69▲ | 9.80▲ | 9.42▲ |
| MA200 | 9.69▲ | 9.69▲ | 9.73▲ | 9.78▲ | 9.07▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | -0.010▼ | -0.012▼ | 0.007▲ | 0.003▲ |
| RSI | 41.929▼ | 45.044▼ | 46.307▼ | 53.593▲ | 51.227▲ |
| STOCH | 10.370▼ | 9.942▼ | 15.596▼ | 72.745 | 72.316 |
| WILL %R | -72.727 | -72.727 | -72.727 | -47.619 | -34.375 |
| CCI | -40.862 | -52.463 | -76.482 | -25.091 | 50.052 |
|
Monday, November 17, 2025 09:00 AM
You should not draw any conclusions about the Funds’ investment performance from the amount of this distribution or from the terms of the Funds’ Plan. The Funds’ estimate that it has distributed more ...
|
|
Saturday, November 08, 2025 01:13 AM
(RTTNews) - Takeda Pharmaceutical Company Limited (TAK) announced new interim findings from its Phase 1b open-label proof-of-concept trial evaluating subcutaneous mezagitamab (TAK-079), an anti-CD38 ...
|
|
Wednesday, October 15, 2025 01:40 PM
Voya Global Advantage and Premium Opportunity Fund (NYSE:IGA) declares $0.085/share monthly dividend. Forward yield 10.26% Payable Nov. 17; for shareholders of record Nov. 3; ex-div Nov. 3. See IGA ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/12/25 | 9.80 | 9.80 | 9.77 | 9.80 | 74,550 |
| 29/12/25 | 9.89 | 9.89 | 9.84 | 9.86 | 37,300 |
| 26/12/25 | 9.90 | 9.90 | 9.86 | 9.89 | 35,300 |
| 24/12/25 | 9.88 | 9.88 | 9.84 | 9.87 | 29,400 |
| 23/12/25 | 9.84 | 9.87 | 9.81 | 9.85 | 33,100 |
| 22/12/25 | 9.85 | 9.89 | 9.73 | 9.81 | 59,200 |
| 19/12/25 | 9.78 | 9.84 | 9.77 | 9.80 | 60,000 |
| 18/12/25 | 9.76 | 9.8399 | 9.73 | 9.76 | 35,426 |
| 17/12/25 | 9.73 | 9.81 | 9.73 | 9.73 | 47,500 |
| 16/12/25 | 9.79 | 9.83 | 9.75 | 9.76 | 67,747 |
|
|
||||
|
|
||||
|
|